Tech Company Financing Transactions

Cebix Funding Round

InterWest Partners, Sofinnova Ventures, Thomas and McNerny & Partners joined a $2.3 million funding round for Cebix. This venture round was recorded on 12/31/2014.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Out of Business
Mailing Address
1298 Prospect St. 2A
La Jolla, CA 92037
Email Address
Cebix is focused on the development of chronic replacement therapy based on human proinsulin C-peptide for the treatment of type 1 diabetic neuropathy. The role of C-peptide will also be explored in type 1 diabetic nephropathy and retinopathy.
Cebix LinkedIn Company Profile
Social Media
Cebix Company Twitter Account
Company News
Cebix News
Cebix on Facebook
Cebix on YouTube

Management Team

Email & Social
Chief Executive Officer
Joel Martin
  Joel Martin LinkedIn Profile  Joel Martin Twitter Account  Joel Martin News  Joel Martin on Facebook
Chief Medical Officer
Dennis Kim
  Dennis Kim LinkedIn Profile  Dennis Kim Twitter Account  Dennis Kim News  Dennis Kim on Facebook
Chief Scientific Officer
John Wahren
  John Wahren LinkedIn Profile  John Wahren Twitter Account  John Wahren News  John Wahren on Facebook
VP - Regulatory Affairs
Michelle Mazzoni
  Michelle Mazzoni LinkedIn Profile  Michelle Mazzoni Twitter Account  Michelle Mazzoni News  Michelle Mazzoni on Facebook



Browse more venture capital transactions:

Prev: 12/31/2014: NuSirt Biopharma venture capital transaction
Next: 12/31/2014: Wright Therapy Products venture capital transaction


Share this article


News on VC Transactions

We do our best to record funding rounds that are announced publicly. VC investment data records reported here come from publicly available VC deal announcements. The data is sourced from, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary